Literature DB >> 21339395

Polypectomy compared with ethmoidectomy in the treatment of nasal polyposis.

Marie Devars du Mayne1, Virginie Prulière-Escabasse, Françoise Zerah-Lancner, André Coste, Jean-François Papon.   

Abstract

OBJECTIVE: To compare the 3-year results of 2 endoscopic surgical approaches in the management of nasal polyposis.
DESIGN: Retrospective medical record review.
SETTING: Private or institutional practice. PATIENTS: A total of 127 patients with nasal polyposis were operated on by the same surgeon between January 1, 2003, and September 31, 2005. INTERVENTION: The patients underwent radical ethmoidectomy (n = 77) and polypectomy (n = 50). MAIN OUTCOME MEASURES: Outcome measures were global functional score, calculated by summing the scores (0-3) of each symptom (congestion, rhinorrhea, anosmia, hyperreactivity, and pain); global anatomical score (GAS), calculated by summing the score of polyp development for each nasal cavity; computed tomography score; adherence to corticosteroid therapy; oral corticosteroid consumption; and complication and subsequent operation rate. Efficacy was evaluated by comparing these data preoperatively and postoperatively (at 3 months, 1 year, and 3 years).
RESULTS: The global functional score and GAS were significantly improved 3 years after these techniques were performed (global functional score changes from 8.65 to 3.11 for ethmoidectomy and from 8.15 to 4.2 for polypectomy; GAS, from 5.95 to 1.83 for ethmoidectomy and from 6.57 to 3.58 for polypectomy). Congestion, pain, and GAS were improved to a significantly greater extent in the ethmoidectomy group. The subsequent operation rate for symptomatic polyp recurrence was comparable (9.1% vs 8.0%), with fewer local complications in the polypectomy group.
CONCLUSION: Polypectomy seems to represent a valuable alternative in the armamentarium of first-hand surgical procedures for treating nasal polyposis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21339395     DOI: 10.1001/archoto.2010.255

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  7 in total

Review 1.  Danger points, complications and medico-legal aspects in endoscopic sinus surgery.

Authors:  W Hosemann; C Draf
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

2.  Assessment of quality-of-life outcomes after surgery for nasal polyposis with the DyNaChron questionnaire.

Authors:  Duc Trung Nguyen; Francis Guillemin; Fabien Arous; Roger Jankowski
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-05       Impact factor: 2.503

3.  Evaluation of a Dermoplasty Technique for the Control on Nasal Polyps.

Authors:  George Anastasopoulos; Eleftherios Ferekidis
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-29

4.  The potential role of peak nasal inspiratory flow to evaluate active sinonasal inflammation and disease severity.

Authors:  José Araújo-Martins; Carlos Brás-Geraldes; Nuno Neuparth
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

5.  Critical Evaluation of Sinonasal Disease in 64 Adults with Primary Ciliary Dyskinesia.

Authors:  Emilie Bequignon; Laurence Dupuy; Francoise Zerah-Lancner; Laurence Bassinet; Isabelle Honoré; Marie Legendre; Marie Devars du Mayne; Virginie Escabasse; Bruno Crestani; Bernard Maître; Estelle Escudier; André Coste; Jean-François Papon
Journal:  J Clin Med       Date:  2019-05-07       Impact factor: 4.241

Review 6.  A review of the revisions and complications management procedure in sinus surgery.

Authors:  Sara Khademi; Aida Kazemi; Reza Divanbeigi; Mohamadreza Afzalzadeh
Journal:  J Family Med Prim Care       Date:  2022-03-10

7.  Follow-Up and Management of Chronic Rhinosinusitis in Adults with Primary Ciliary Dyskinesia: Review and Experience of Our Reference Centers.

Authors:  Emilie Bequignon; Laurence Dupuy; Virginie Escabasse; Francoise Zerah-Lancner; Laurence Bassinet; Isabelle Honoré; Marie Legendre; Marie Devars du Mayne; Bruno Crestani; Estelle Escudier; André Coste; Jean-François Papon; Bernard Maître
Journal:  J Clin Med       Date:  2019-09-19       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.